Article
Cyclopamine modulates smoothened receptor activity in a binding position dependent manner.
Communications biology - 28 Sept 2024
Kim Kihong, Bansal Prateek D, Shukla Diwakar
Abstract excerpt
Cyclopamine, a natural alkaloid, can act as an agonist when it binds to the Cysteine-Rich Domain (CRD) of Smoothened receptor and as an antagonist when it binds to the Transmembrane Domain (TMD). To study the effect of cyclopamine binding to each site experimentally, mutations in the other site are required. Hence, simulations are critical for understanding the WT activity due to binding at different sites. Using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
